Age, Biography and Wiki

Sheridan Snyder was born on 20 October, 1936 in Long Island, New York, is an American businessperson. Discover Sheridan Snyder's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is he in this year and how he spends money? Also learn how he earned most of networth at the age of 87 years old?

Popular As N/A
Occupation Chairman and CEO, BioCatalyst International
Age 87 years old
Zodiac Sign Libra
Born 20 October 1936
Birthday 20 October
Birthplace Long Island, New York
Nationality United States

We recommend you to check the complete list of Famous People born on 20 October. He is a member of famous businessperson with the age 87 years old group.

Sheridan Snyder Height, Weight & Measurements

At 87 years old, Sheridan Snyder height not available right now. We will update Sheridan Snyder's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.

Physical Status
Height Not Available
Weight Not Available
Body Measurements Not Available
Eye Color Not Available
Hair Color Not Available

Dating & Relationship status

He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.

Family
Parents Not Available
Wife Not Available
Sibling Not Available
Children Not Available

Sheridan Snyder Net Worth

His net worth has been growing significantly in 2023-2024. So, how much is Sheridan Snyder worth at the age of 87 years old? Sheridan Snyder’s income source is mostly from being a successful businessperson. He is from United States. We have estimated Sheridan Snyder's net worth, money, salary, income, and assets.

Net Worth in 2024 $1 Million - $5 Million
Salary in 2024 Under Review
Net Worth in 2023 Pending
Salary in 2023 Under Review
House Not Available
Cars Not Available
Source of Income businessperson

Sheridan Snyder Social Network

Instagram
Linkedin
Twitter
Facebook
Wikipedia
Imdb

Timeline

1936

Sheridan Gray Snyder OBE (born October 20, 1936) is an entrepreneur, venture capitalist, and philanthropist in the biotechnology industry.

He is the founder and CEO of Biocatalyst, Genzyme and others.

1958

Snyder graduated from The Lawrenceville School in New Jersey and is a 1958 graduate of The University of Virginia with a Bachelor of Arts in French & Romance Languages.

At UVa, Snyder was a member of the SPE social fraternity.

1968

Glassmeyer, a Princeton graduate, began in venture capitalism in 1968 to 1970 at CitiCorp Venture Capital.

1970

By 1970 Snyder had sold Cambridge Machine Corporation to Pitney-Bowes and he began working for them as National Sales Account manager.

1971

In 1971, Snyder founded a start-up packaging company, Instapak, funded by venture capitalist, Ed Glassmeyer.

Instapak markets "foam-in-place packaging"—revolutionary for its time— that creates a protective barrier for heavy, fragile instrumentation and computer systems.

Instapak is now the largest division of Sealed Air Corporation (NYSE: SEE), with more than 5,500 employees and revenues of $1 billion.

1978

By 1978 he co-founded Oak Investment Partners with Stewart Greenfield and became Managing Partner.

Snyder's start-up Cambridge Machine Corporation, initiated the development and invention of high-speed mailing/envelope inserting machines.

1980

These "well-known, full professors who had a lot of multidisciplinary post-docs" had formed a successful Boston-based business management consulting firm a Bio Information Associates (BIA) in 1980.

As Termeer described it, "Genzyme was just these professors from MIT and myself and some venture capitalists."

One of these professors was a Harvard chemistry professor, George M. Whitesides who founded many companies.

He is considered to be Genzyme's co-founder.

1981

In 1981, Glassmeyer's entry into the then-embryonic biotechnology industry by starting up Genzyme—a biotechnology firm—was in response to Glassmeyer's challenge.

In its earliest moments "Genzyme was just really the combination" of Snyder and Henry Blair, a technician at the New England Enzyme Center at Tufts Medical School, who had worked for Roscoe Brady at the National Institute of Health (NIH).

According to Snyder, he and Blair "started developing a business on our own."

Blair had a contract with the National Institutes of Health (NIH) to produce modified enzymes for the NIH and test it in clinical trials.

Roscoe and his colleagues had been working on a treatment for Gaucher's disease for over a decade at that time.

Snyder was transformed by the idea that entrepreneurs could "actually help people and save some lives."

Genzyme's first office was an old clothing warehouse adjacent to Tufts Medical School.

1983

By 1983 Genzyme interviewed Baxter employee Henri Termeer, who had completed his MBA at Snyder's alma mater, the University of Virginia in 1973.

By that time Genzyme had seventeen employees who worked in an old clothing warehouse adjacent to Tufts Medical School.

Genzyme also had a small diagnostics operation in England.

By 1983 Genzyme developed close ties with a group of entrepreneurial professors from MIT and Harvard.

1985

Snyder served as Genzyme's first Chairman, President and CEO until Henri Termeer was appointed as CEO in 1985.

1986

In 1986, Snyder initiated the first sale of Genzyme stock shares (Initial Public Offering).

"In the formative years of biotechnology, Genzyme was the industry’s Apple, blazing a pathway for creating protein-based treatments for rare diseases."

1988

In 1988 Termeer took over as Genzyme's Chairman.

1994

In 1994 Snyder founded Argonex a small biotech start-up in Charlottesville, Virginia.

1996

In 1996, Snyder founded and served as chairman and chief executive officer of Upstate Biotechnology Incorporated, merging it with Argonex.

Upstate Inc. develops cell signaling products, technology platforms and services.

1999

In 1999, the State of Virginia honored Snyder with its Biotechnology Lifetime Achievement Award.

2002

Snyder received an Honorary Doctorate of Law degree from the University of Dundee in 2002.

Ed Glassmeyer, Senior Manager of the venture capital firm Oak Partners, funded many of Snyder's early start-up companies, mainly in electronics.

2003

In 2003, he was appointed to Scotland’s International Advisory Board and serves as an advisor to the Scottish government on the development of its biotech sector.

In this capacity, Snyder played a role with the development of an 800000 sqft bioscience translational center outside Edinburgh.

2004

Upstate was sold to Serologicals Corporation in 2004 for $205 million.

2005

Snyder was honored OBE (Officer of the Order of the British Empire) in 2005 by HM Queen Elizabeth II of the United Kingdom on the advice of the British government.